Low-dose of tetravalent inactivated enterovirus vaccine (Vero cell)
PRO-QEV-1001
Phase 2 mab completed
Quick answer
Low-dose of tetravalent inactivated enterovirus vaccine (Vero cell) for Hand, Foot, and Mouth Disease (HFMD) is a Phase 2 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- Hand, Foot, and Mouth Disease (HFMD)
- Phase
- Phase 2
- Modality
- mab
- Status
- completed